Capital Advisors Inc’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5.72M Buy
22,507
+141
+0.6% +$32.9K 0.08% 104
2026
Q1
$5.47M Buy
22,366
+605
+3% +$141K 0.09% 103
2025
Q4
$4.5M Sell
21,761
-229
-1% -$45.3K 0.07% 105
2025
Q3
$4.08M Sell
21,990
-3,530
-14% -$605K 0.07% 104
2025
Q2
$3.9M Buy
25,520
+2,562
+11% +$394K 0.07% 104
2025
Q1
$3.81M Sell
22,958
-18,521
-45% -$2.9M 0.08% 102
2024
Q4
$6M Sell
41,479
-7,709
-16% -$1.19M 0.12% 95
2024
Q3
$7.97M Sell
49,188
-1,256
-2% -$200K 0.16% 92
2024
Q2
$7.37M Sell
50,444
-16,363
-24% -$2.43M 0.15% 96
2024
Q1
$10.6M Sell
66,807
-232,731
-78% -$37M 0.23% 91
2023
Q4
$46.9M Buy
299,538
+5,226
+2% +$801K 1.05% 30
2023
Q3
$45.8M Buy
294,312
+20,555
+8% +$3.39M 1.2% 26
2023
Q2
$45.3M Buy
273,757
+13,962
+5% +$2.25M 1.15% 28
2023
Q1
$40.3M Buy
259,795
+26,898
+12% +$4.34M 1.08% 30
2022
Q4
$41.1M Buy
232,897
+6,626
+3% +$1.14M 1.17% 29
2022
Q3
$37.2M Buy
226,271
+136,784
+153% +$23.1M 1.15% 29
2022
Q2
$15.9M Sell
89,487
-2,001
-2% -$357K 0.48% 77
2022
Q1
$16.2M Sell
91,488
-367
-0.4% -$62.4K 0.44% 79
2021
Q4
$15.7M Buy
91,855
+1,704
+2% +$279K 0.42% 81
2021
Q3
$14.6M Sell
90,151
-47
-0.1% -$8.02K 0.43% 83
2021
Q2
$14.9M Buy
90,198
+339
+0.4% +$56.1K 0.45% 84
2021
Q1
$14.8M Buy
89,859
+300
+0.3% +$48.5K 0.48% 80
2020
Q4
$14.1M Buy
89,559
+4,611
+5% +$680K 0.5% 74
2020
Q3
$12.6M Buy
84,948
+2,647
+3% +$392K 0.51% 71
2020
Q2
$12.1M Buy
82,301
+1,986
+2% +$289K 0.51% 70
2020
Q1
$10.5M Sell
80,315
-684
-0.8% -$97K 0.57% 62
2019
Q4
$11.8M Buy
80,999
+2,133
+3% +$289K 0.51% 73
2019
Q3
$11M Hold
78,866
0.54% 63
2019
Q2
$11M Buy
78,866
+9,517
+14% +$1.32M 0.54% 63
2019
Q1
$9.69M Sell
69,349
-7,737
-10% -$1.04M 1.04% 12
2018
Q4
$9.95M Buy
77,086
+1,253
+2% +$175K 0.65% 49
2018
Q3
$10.5M Buy
75,833
+183
+0.2% +$24.3K 0.62% 52
2018
Q2
$9.18M Sell
75,650
-1,446
-2% -$180K 0.55% 61
2018
Q1
$9.88M Sell
77,096
-2,215
-3% -$299K 0.59% 55
2017
Q4
$11.1M Buy
79,311
+95
+0.1% +$13.2K 0.65% 51
2017
Q3
$10.3M Sell
79,216
-6,743
-8% -$894K 0.63% 58
2017
Q2
$11.4M Sell
85,959
-60,195
-41% -$7.68M 0.71% 52
2017
Q1
$18.2M Buy
146,154
+11,003
+8% +$1.31M 1.19% 18
2016
Q4
$15.6M Buy
135,151
+69,918
+107% +$8.08M 1.08% 20
2016
Q3
$7.71M Sell
65,233
-4,649
-7% -$564K 1.15% 44
2016
Q2
$8.48M Buy
69,882
+877
+1% +$99.7K 1.31% 36
2016
Q1
$7.47M Sell
69,005
-1,042
-1% -$108K 1.22% 39
2015
Q4
$7.2M Buy
70,047
+611
+0.9% +$61.4K 1.26% 36
2015
Q3
$6.48M Buy
69,436
+552
+0.8% +$53.4K 1.17% 42
2015
Q2
$6.71M Sell
68,884
-70,640
-51% -$7.07M 1.15% 48
2015
Q1
$14M Buy
139,524
+75,808
+119% +$7.71M 1.73% 8
2014
Q4
$6.66M Buy
63,716
+496
+0.8% +$52.3K 1.23% 45
2014
Q3
$6.74M Sell
63,220
-10,397
-14% -$1.08M 1.38% 38
2014
Q2
$7.7M Sell
73,617
-1,395
-2% -$141K 1.49% 23
2014
Q1
$7.37M Sell
75,012
-855
-1% -$79.3K 1.6% 20
2013
Q4
$6.95M Sell
75,867
-702
-0.9% -$64.7K 1.53% 24
2013
Q3
$6.64M Buy
76,569
+234
+0.3% +$21K 1.59% 22
2013
Q2
$6.55M Buy
+76,335
New +$6.48M 1.77% 18

Other funds holding JNJ

Capital Advisors Inc's JNJ Position: Q2 2026 in Review

Capital Advisors Inc increased its Johnson & Johnson (JNJ) stake by 0.63% in Q2 2026, buying an estimated $32.9K and bringing the position to 22,507 shares worth $5.72M. The position accounts for 0.08% of the portfolio, ranked #104.

Capital Advisors Inc first reported a position in JNJ in Q2 2013 and has held it in 53 quarters since. The position peaked at $46.9M in Q4 2023. 4,665 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Capital Advisors Inc held 22,507 shares of Johnson & Johnson worth $5.72M as of Q2 2026.
  • Capital Advisors Inc bought 141 Johnson & Johnson shares in Q2 2026, an estimated $32.9K.
  • Johnson & Johnson made up 0.08% of Capital Advisors Inc's portfolio in Q2 2026, its #104 holding.
  • Capital Advisors Inc first reported a position in Johnson & Johnson in Q2 2013 and has held it in 53 quarters since.
  • Capital Advisors Inc's Johnson & Johnson position peaked at $46.9M in Q4 2023.
  • 4,665 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Capital Advisors Inc's 13F filing for Q2 2026, filed 23 Jul 2026.